SBMFF OTC
Sino Biopharmaceutical Limited
1W: +0.0%
1M: -5.8%
3M: +17.2%
YTD: -20.3%
1Y: -36.2%
3Y: +111.9%
5Y: -9.8%
$0.69
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$12.4B
52W Range0.5928-1.09
Volume1,000
Avg Volume270
Beta0.60
Dividend$0.01
Analyst Ratings
No analyst coverage
Company Info
CEOS. Y. Tse
Employees21,435
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2010-02-22
Websitesbpgroup.com
Unit 09, Office Tower
Hong Kong
HK
Hong Kong
HK
852 2802 9886
About Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is an investment holding company that operates as an integrated pharmaceutical enterprise. It researches, develops, manufactures, and markets a wide range of modernized Chinese medicines and chemical medicines. The company's therapeutic areas of focus include oncology, liver disease, respiratory, and surgery/pain relief, with its primary market being mainland China. [9, 12, 15, 19]
Latest News
Chinese biopharma stocks rally as U.S. signals openness to drug licensing
Sino Biopharmaceutical Forms Indonesia Joint Venture With Tempo Scan - The Globe and Mail
Sino Biopharma receives Chinese rights to two GSK respiratory drugs - Seeking Alpha
AstraZeneca to pay $200M upfront for Sino Biopharmaceutical’s COPD drug license deal - Seeking Alpha
AstraZeneca to pay $200M upfront for Sino Biopharmaceutical’s COPD drug license deal
Recent Insider Trades
No insider trades found